34 citations
Counting papers with at most 25 authors, so collaboration author lists do not stand in for the people here.
- Eli Lilly (United States)US2 papers
- AbbVie (Japan)1 paper
- AbbVie (United States)US1 paper
- Bayer (Canada)CA1 paper
- Berkeley CollegeUS1 paper
- CSL (Switzerland)CH1 paper
- Day Kimball HealthcareUS1 paper
- Eli Lilly (Singapore)SG1 paper
- North Carolina State UniversityUS1 paper
- United States Food and Drug AdministrationUS1 paper
- University of California, BerkeleyUS1 paper
Showing stat.MEShow all
2 papers · 1 filter
stat.ME2023★ 3 cited
Sensitivity Analysis for Unmeasured Confounding in Medical Product Development and Evaluation Using Real World Evidence
Yixin Fang, Pallavi Mishra-Kalyani, Xiang Zhang +8
The American Statistical Association Biopharmaceutical Section (ASA BIOP) scientific working group on real-world evidence (RWE) has been making continuous, extended efforts towards…
stat.ME2021★ 34 cited
Using principal stratification in analysis of clinical trials
Ilya Lipkovich, Bohdana Ratitch, Yongming Qu +3
The ICH E9(R1) addendum (2019) proposed principal stratification (PS) as one of five strategies for dealing with intercurrent events. Therefore, understanding the strengths, limita…